1-9 of 9
Jin Xie
Close
Sort by
Journal Articles

An Inflammatory Biomarker Signature Reproducibly Predicts CAR-T Treatment Failure in Patients with Aggressive Lymphoma across the Zuma Trials Cohorts

Sandeep Raj, Jin Xie, Teng Fei, Qinghua Song, Jenny J. Kim, Christina To, Marcel R.M. van den Brink, Miguel-Angel Perales, Mike Mattie, Roni Shouval
Journal: Blood
Blood (2023) 142 (Supplement 1): 224.
https://doi.org/10.1182/blood-2023-173798
Published: 2023
Journal Articles

Minority Patients in the US Receiving Chimeric Antigen Receptor (CAR) T-Cell Therapy: A SEER-Based Simulation on Representation and Impact of Proximity to Authorized Treatment Center (ATC)

Mendel Goldfinger, Zhen-Huan Hu, Aaron P. Rapoport, Tanya Siddiqi, Lazaros J. Lekakis, Marcelo C Pasquini, Shilpa Shahani, Elande Baro, Jin Xie, Qinghua Song, Fang Sun, Hairong Xu, Frederick L. Locke
Journal: Blood
Blood (2022) 140 (Supplement 1): 9520–9522.
https://doi.org/10.1182/blood-2022-166510
Published: 2022
Journal Articles

Frequency, Health Care Resource Use (HCRU), and Costs Associated With Skeletal Related Events (SREs) In US Patients With Multiple Myeloma (MM)

Emily Nash Smyth, PharmD, Ilaria Conti, MD, PhD, James Wooldridge, MD, Lee Bowman, PhD, Li Li, PhD, David Nelson, MS, Jin Xie, MS, Daniel E Ball, DrPH
Journal: Blood
Blood (2013) 122 (21): 2968.
https://doi.org/10.1182/blood.V122.21.2968.2968
Published: 2013
Journal Articles

A Retrospective Observational Study of Annual Healthcare Costs for Patients with Forms of Myeloproliferative Neoplasms (MPN)

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2060.
https://doi.org/10.1182/blood.V118.21.2060.2060
Published: 2011
Journal Articles

A Retrospective Observational Comparison of Comorbidities Between Myeloproliferative Neoplasm (MPN) Patients and Matched Controls in a Commercially Insured US Population

Gregory L Price, MPH, Gerhardt M Pohl, PhD, Jin Xie, MS, Richard A Walgren, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3140.
https://doi.org/10.1182/blood.V118.21.3140.3140
Published: 2011
Journal Articles

Dickkopf-1 (DKK1) is a widely expressed and potent tumor-associated antigen in multiple myeloma

Jianfei Qian, Jin Xie, Sungyoul Hong, Jing Yang, Liang Zhang, Xiaohong Han, Michael Wang, Fenghuang Zhan, John D. Shaughnessy, Jr, Joshua Epstein, Larry W. Kwak, Qing Yi
Journal: Blood
Blood (2007) 110 (5): 1587–1594.
https://doi.org/10.1182/blood-2007-03-082529
Published: 2007
Journal Articles

Myeloma Cell-Derived Factors Retard the Differentiation and Function of Dendritic Cells.

Qing Yi, MD, PhD, Siqing Wang, MD, Jin Xie, PhD, Jianfei Qian, PhD, Jin Yang, PhD, Muta E. Freeman, BS, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2447.
https://doi.org/10.1182/blood.V104.11.2447.2447
Published: 2004
Journal Articles

Generation of Tumor-Specific Cytotoxic T Lymphocytes in Multiple Myeloma Using Dendritic Cells Pulsed with Tumor-Derived Heat Shock Protein gp96.

Qing Yi, MD, PhD, Jianfei Qian, PhD, Jin Xie, PhD, Siqing Wang, MD, Muta E. Freeman, BS, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 2451.
https://doi.org/10.1182/blood.V104.11.2451.2451
Published: 2004
Journal Articles

β 2 -Microglobulin as a negative regulator of the immune system: high concentrations of the protein inhibit in vitro generation of functional dendritic cells

Jin Xie, Ying Wang, Muta E. Freeman, III, Bart Barlogie, Qing Yi
Journal: Blood
Blood (2003) 101 (10): 4005–4012.
https://doi.org/10.1182/blood-2002-11-3368
Published: 2003